- Home
- INDV vs TDS Comparison
INDV vs TDS Comparison
Compare INDV & TDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | TDS |
|---|---|---|
| Founded | N/A | 1968 |
| Country | United States | United States |
| Employees | N/A | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.5B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | INDV | TDS |
|---|---|---|
| Price | $40.43 | $34.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $53.33 |
| AVG Volume (30 Days) | ★ 1.6M | 1.0M |
| Earning Date | 06-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $1,239,000,000.00 | N/A |
| Revenue This Year | N/A | $4.05 |
| Revenue Next Year | N/A | $1.72 |
| P/E Ratio | $59.86 | ★ N/A |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $15.00 | $34.13 |
| 52 Week High | $42.81 | $49.12 |
Technical Indicators
Market Signals| Indicator | INDV | TDS |
|---|---|---|
| Relative Strength Index (RSI) | 57.41 | 22.71 |
| Support Level | $35.36 | N/A |
| Resistance Level | $41.00 | $40.30 |
| Average True Range (ATR) | 1.56 | 1.21 |
| MACD | -0.06 | -0.27 |
| Stochastic Oscillator | 55.32 | 5.31 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About TDS Telephone and Data Systems Inc.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides communications services to customers through broadband, video, voice, and wireless connections. The company has two reportable segments: TDS Telecom and Array. The majority of its revenue is generated from the TDS Telecom segment, which generates revenue by providing broadband, video, voice, and wireless services. The Array segment generates its revenue mainly by leasing tower space on Array-owned towers to customers.